Preskorn Sh
- Psychiatry and Mental health top 5%
- Electroconvulsive Therapy Studies 3
- Attention Deficit Hyperactivity Disorder 2
- Pharmacology top 5%
- Treatment of Major Depression 7
- Pharmacogenetics and Drug Metabolism 2
- Behavioral Neuroscience top 10%
- Stress Responses and Cortisol 1
- Clinical Psychology top 10%
- Child and Adolescent Psychosocial and Emotional Development 2
-
- Analytical Methods in Pharmaceuticals 2
-
- Pharmacological Effects and Assays 2
- Co-authors
- Greenblatt DjElizabeth B. WellerRonald A. WellerIi‐Sei WatanabeR HassaneinCarroll W. HughesEdwards Wd
- Journals
- The Journal of Clinical Psychiatry (1 paper)PubMed (22 papers)Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (1 paper)
- Partner nations
- United States
In The Last Decade
Preskorn Sh
24 papers receiving 458 citations
Peers
Comparison fields: 5 of 75
- Psychiatry and Mental health 253
- Pharmacology 203
- Behavioral Neuroscience 33
- Biological Psychiatry 18
- Clinical Psychology 140
Countries citing papers authored by Preskorn Sh
This map shows the geographic impact of Preskorn Sh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Preskorn Sh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Preskorn Sh more than expected).
Fields of papers citing papers by Preskorn Sh
This network shows the impact of papers produced by Preskorn Sh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Preskorn Sh. The network helps show where Preskorn Sh may publish in the future.
Co-authorship network
The 7 scholars most cited alongside Preskorn Sh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Sertraline does not inhibit cytochrome P450 3A-mediated drug metabolism in vivo. | 1997 | 27 |
| 2 | Reducing the risk of drug-drug interactions: a goal of rational drug development. | 1996 | 13 |
| 3 | Update on antidepressant therapy. | 1994 | 3 |
| 4 | Pharmacoeconomic considerations when evaluating treatment options for major depressive disorder. | 1994 | 18 |
| 5 | Introduction. Pharmacokinetics of psychotropic agents: why and how they are relevant to treatment. | 1993 | 9 |
| 6 | Should bupropion dosage be adjusted based upon therapeutic drug monitoring? | 1991 | 24 |
| 7 | Therapeutic drug monitoring of tricyclic antidepressants: a standard of care issue. | 1989 | 8 |
| 8 | Tricyclic antidepressants: the whys and hows of therapeutic drug monitoring. | 1989 | 24 |
| 9 | Depression in children: concentration-dependent CNS toxicity of tricyclic antidepressants. | 1988 | 20 |
| 10 | Plasma monitoring of tricyclic antidepressants: defining the therapeutic range for imipramine in depressed children. | 1986 | 2 |
| 11 | Tricyclic antidepressant plasma level monitoring: an improvement over the dose-response approach. | 1986 | 12 |
| 12 | The dexamethasone suppression test in prepubertal depressed children. | 1985 | 17 |
| 13 | Plasma levels of amitriptyline: effect of age and sex. | 1985 | 36 |
| 14 | The implication of concentration/response studies of tricyclic antidepressants for psychiatric research and practice. | 1984 | 7 |
| 15 | Depression in children. Effects of antidepressant therapy. | 1983 | 4 |
| 16 | Toxicity of tricyclic antidepressants--kinetics, mechanism, intervention: a review. | 1982 | 69 |
| 17 | Progressive multifocal leukoencephalopathy: cerebral mass lesions. | 1979 | 7 |
| 18 | Dosage schedule and plasma levels of doxepin and desmethyldoxepin. | 1978 | 9 |
| 19 | Imipramine and desipramine plasma levels: relationship to dosage schedule and sampling time. | 1978 | 6 |
| 20 | The deadliest rupture: idiopathic muscular hypertrophy of the esophagus. | 1977 | 2 |
About Preskorn Sh
Preskorn Sh is a scholar working on Pharmacology, Psychiatry and Mental health and Behavioral Neuroscience, having authored 24 papers that have together received 520 indexed citations. Recurring topics across this work include Treatment of Major Depression (7 papers), Electroconvulsive Therapy Studies (3 papers), Attention Deficit Hyperactivity Disorder (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Analytical Methods in Pharmaceuticals (2 papers), Child and Adolescent Psychosocial and Emotional Development (2 papers), Pharmacological Effects and Assays (2 papers) and Stress Responses and Cortisol (1 paper). The work is most often cited by research in Psychiatry and Mental health (253 citations), Pharmacology (203 citations) and Behavioral Neuroscience (33 citations). Preskorn Sh has collaborated with scholars based in United States. Frequent co-authors include Greenblatt Dj, Elizabeth B. Weller, Ronald A. Weller, Ii‐Sei Watanabe, R Hassanein, Carroll W. Hughes and Edwards Wd. Their work appears in journals such as The Journal of Clinical Psychiatry, PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.